1- Assistant Professor, Department of Medical Oncology, Bu Ali Hospital, Tehran Medical Science Branch, Islamic Azad University of Tehran, Tehran, Iran , a_shahra@hotmail.com 2- Medical Student, Tehran Medical Sciences Branch, Islamic Azad University of Tehran, Tehran, Iran
Abstract: (3488 Views)
Paraneoplastic syndromes are generally defined as clinical disorder associated with malignant diseases, and hypocalcemia as paraneoplastic manifestation associated with cancer is a rare condition. In patient with bone metastatic cancer, osteolytic lesions are more common than osteoblastic ones which give rise to hypercalcemia and hypocalcemia is a rare condition in this group of patients. We described a 56-year-old male with the history of gastric cancer and gastrectomy and chemotherapy since one year ego who came to clinic with complaints of nausea, vomiting and paresthesia of extremities which after diagnostic work up, paraneoplastic hypocalcemia was diagnosed. Hypocalcemia following bone metastasis is not a common phenomenon, but in patients with the history of gastric cancer and neurological symptoms (paresthesia, …) evaluation of serum calcium value is recommended.
1. Okazaki J, Muguruma N, Kitamura S, Kimura T, Okamoto K, Miyamoto H, et al. Paraneoplastic hypocalcemia developed in gastric cancer accompanied by osteoblastic metastasis. Intern Med 2017; 56: 1345-1349. [DOI:10.2169/internalmedicine.56.8545]
2. Dimitriadis GK, Angelousi A, Weickert MO, Randeva HS, Kaltsas G, Grossman A. Paraneoplastic endocrine syndromes. Endocr Relat Cancer 2017;24: R173-R190. [DOI:10.1530/ERC-17-0036]
3. Raskin P, McClain CJ, Medsger TA. Hypocalcemia associated with metastatic bone disease: a retrospective study. Arch Intern Med 1973;132: 539-543. [DOI:10.1001/archinte.1973.03650100057011]
4. Chung YS, Choi TY, Ha CY, Kim HM, Lee KJ, Park CH, et al. An unusual case of osteoblastic metastasis from gastric. Yonsei Med J 2002;43: 377-380. [DOI:10.3349/ymj.2002.43.3.377]
5. Fonocho E, Aydin N, Reddy S, Misra S. Recurrent gastric cancer metastasizing to the bone marrow: A case report of a rare presentation. Int J Surg Case Rep 2017;37: 165-168. [DOI:10.1016/j.ijscr.2017.06.025]
6. Diniotis B, Sternberg E, Shakuntala S, Chiha M, Khosla P. Hypocalcemia in malignancy-unexpected but common. Cureus 2015; 7:12-18. [DOI:10.7759/cureus.442]
7. Iizumi S, Shimoi T, Nishikawa T, Kitano A, Sasada S, Shimomura A, et al. Prolonged hypocalcemia following a single dose of denosumab for diffuse bone metastasis of gastric cancer after total gastrectomy. Intern Med 2017; 56: 2879-2882, 2017. [DOI:10.2169/internalmedicine.8908-17]
9. Szentirmai M, Constantinou C, Rainey JM, Loewenstein JE. Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer. West J Med 2001; 163: R577.
10. Guise TA, Mohammad, KS, Clines G, Stebbins EG, Wong DH, Higgins LS, et al. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 2006;12: 6213s-6216s. [DOI:10.1158/1078-0432.CCR-06-1007]
11. Kim HS, Yi SY, Jun HJ, Lee J, Park JO, Park YS, et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology 2011;73: 192-197. [DOI:10.1159/000127386]
Shahrasbi A, Heydarzadeh K, Fahimi S, Abbasi fard N. Paraneoplastic hypocalcemia in a patient whit gastric cancer accompanied by osteoblastic metastasis. MEDICAL SCIENCES 2020; 30 (2) :221-225 URL: http://tmuj.iautmu.ac.ir/article-1-1779-en.html